Latham & Watkins has hired the UK Competition and Markets Authority’s director of mergers Jonathan Parker as it rounds out its London offering.
Parker leaves the CMA after two years at the UK’s primary competition and consumer authority, bolstering its merger team after it replaced the UK Competition Commission in early 2014.
He will join Latham’s antitrust & competition practice in May as a partner. Parker is the latest in a string of high-profile antitrust and competition appointments made by Latham in Europe as it beefs up its corporate team, following the arrival of Elisabetta Righini from the European Commission in Brussels. Parker becomes Latham’s fifth competition partner in London and the 20th in Europe.
Latham antitrust and competition practice co-chair Sven Völcker said recent changes to the UK merger regime had raised the stakes for transactions with a UK nexus.
‘This creates obvious challenges in terms of deal certainty and increases the pressure to make notifications of any deals that may face scrutiny. Jonathan’s unique experience and insights will further enhance our ability to offer strategic transactional advice to our clients who are facing an increasingly complex competition landscape.’
Full content: Legal Business
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas